[Source: US Centers for Disease Control and Prevention (CDC), Emerging Infectious Diseases Journal, full page: (LINK). Abstract, edited.]
Volume 25, Number 7—July 2019 / Dispatch
Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA1
Kyle Rizzo , Sam Horwich-Scholefield, and Erin Epson
Author affiliations: California Department of Public Health, Richmond, California, USA
We analyzed antimicrobial susceptibility test results reported in healthcare-associated infections by California hospitals during 2014–2017. Approximately 3.2% of Enterobacteriaceae reported in healthcare-associated infections were resistant to carbapenems and 26.9% were resistant to cephalosporins. The proportion of cephalosporin-resistant Escherichia coli increased 7% (risk ratio 1.07, 95% CI 1.04–1.11) per year during 2014–2017.
Keywords: Antibiotics; Drugs Resistance; Carbapenem; Cephalosporins; Nosocomial Outbreraks; California; USA.